[Synthesis and central none-opioid analgesic activity of SIPI5047]. 2008

Jian-Qi Li, and Li-Ying Huang, and Xin-Jian Chen, and Zhi-Jie Weng, and Chun-Nian Zhang
Shanghai Institute of Pharmaceutical Industry, Shanghai 200040, China. lijq@sipi.com.cn

Compound SIPI5047 was synthesize by using piperazine as starting material in five reaction steps, and its central none-opioid analgesic activity was studied. Its analgesic activity, pharmacological mechanism, action type and drug dependence were well studied in vivo and in vitro. The results show that SIPI5047 has potent analgesic activities in vivo, which is quite similar to morphine and also much more powerful than paracetamol. SIPI5047 has no efficacy to reduce fever or inflammation, but has an obvious action on central nervous system. SIPI5057 has no apparent affinity with the mu-receptor and it is an antagonist that acts on the polyamine site of the NMDA receptor. SIPI5057 appears no drug dependence. SIPI5047 is a novel central none-opioid analgesic agent and more worthy of further research as a new drug candidate.

UI MeSH Term Description Entries
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D010147 Pain Measurement Scales, questionnaires, tests, and other methods used to assess pain severity and duration in patients or experimental animals to aid in diagnosis, therapy, and physiological studies. Analgesia Tests,Analogue Pain Scale,Formalin Test,McGill Pain Questionnaire,Nociception Tests,Pain Assessment,Pain Intensity,Pain Severity,Tourniquet Pain Test,Visual Analogue Pain Scale,Analog Pain Scale,Assessment, Pain,McGill Pain Scale,Visual Analog Pain Scale,Analgesia Test,Analog Pain Scales,Analogue Pain Scales,Formalin Tests,Intensity, Pain,Measurement, Pain,Nociception Test,Pain Assessments,Pain Intensities,Pain Measurements,Pain Questionnaire, McGill,Pain Scale, Analog,Pain Scale, Analogue,Pain Scale, McGill,Pain Severities,Pain Test, Tourniquet,Questionnaire, McGill Pain,Scale, Analog Pain,Scale, Analogue Pain,Scale, McGill Pain,Severity, Pain,Test, Analgesia,Test, Formalin,Test, Nociception,Test, Tourniquet Pain,Tests, Nociception,Tourniquet Pain Tests
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D005260 Female Females
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016194 Receptors, N-Methyl-D-Aspartate A class of ionotropic glutamate receptors characterized by affinity for N-methyl-D-aspartate. NMDA receptors have an allosteric binding site for glycine which must be occupied for the channel to open efficiently and a site within the channel itself to which magnesium ions bind in a voltage-dependent manner. The positive voltage dependence of channel conductance and the high permeability of the conducting channel to calcium ions (as well as to monovalent cations) are important in excitotoxicity and neuronal plasticity. N-Methyl-D-Aspartate Receptor,N-Methyl-D-Aspartate Receptors,NMDA Receptor,NMDA Receptor-Ionophore Complex,NMDA Receptors,Receptors, NMDA,N-Methylaspartate Receptors,Receptors, N-Methylaspartate,N Methyl D Aspartate Receptor,N Methyl D Aspartate Receptors,N Methylaspartate Receptors,NMDA Receptor Ionophore Complex,Receptor, N-Methyl-D-Aspartate,Receptor, NMDA,Receptors, N Methyl D Aspartate,Receptors, N Methylaspartate
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

Jian-Qi Li, and Li-Ying Huang, and Xin-Jian Chen, and Zhi-Jie Weng, and Chun-Nian Zhang
April 1990, Agents and actions,
Jian-Qi Li, and Li-Ying Huang, and Xin-Jian Chen, and Zhi-Jie Weng, and Chun-Nian Zhang
February 2023, Science advances,
Jian-Qi Li, and Li-Ying Huang, and Xin-Jian Chen, and Zhi-Jie Weng, and Chun-Nian Zhang
January 1990, Pharmacological research,
Jian-Qi Li, and Li-Ying Huang, and Xin-Jian Chen, and Zhi-Jie Weng, and Chun-Nian Zhang
January 1989, Pharmacological research,
Jian-Qi Li, and Li-Ying Huang, and Xin-Jian Chen, and Zhi-Jie Weng, and Chun-Nian Zhang
January 1997, Acta anaesthesiologica Scandinavica,
Jian-Qi Li, and Li-Ying Huang, and Xin-Jian Chen, and Zhi-Jie Weng, and Chun-Nian Zhang
May 2003, Life sciences,
Jian-Qi Li, and Li-Ying Huang, and Xin-Jian Chen, and Zhi-Jie Weng, and Chun-Nian Zhang
July 2001, Phytomedicine : international journal of phytotherapy and phytopharmacology,
Jian-Qi Li, and Li-Ying Huang, and Xin-Jian Chen, and Zhi-Jie Weng, and Chun-Nian Zhang
January 1996, Acta physiologica Hungarica,
Jian-Qi Li, and Li-Ying Huang, and Xin-Jian Chen, and Zhi-Jie Weng, and Chun-Nian Zhang
April 1992, European journal of pharmacology,
Jian-Qi Li, and Li-Ying Huang, and Xin-Jian Chen, and Zhi-Jie Weng, and Chun-Nian Zhang
December 1994, Science (New York, N.Y.),
Copied contents to your clipboard!